Long-term follow-up of ischaemic retinopathy in the antiphospholipid syndrome with lupus-like disease

Eye (Basingstoke)

Volumn 14, Issue 3, 2000, Pages 313-317

  Kent, D ^a,b   Hickey Dwyer, Marie ^a   Clark, D ^b  

^a Countess of Chester Hospital ^*  (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Anticardiolipin antibody; Antiphospholipid syndrome; Lupus anticoagulant; Retinal ischaemia

Indexed keywords

ANTICOAGULANT AGENT; PREDNISOLONE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; REPERFUSION; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINOPATHY; VISUAL IMPAIRMENT;

EID: 0033926701     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2000.79     Document Type: Article

References (35)

1. Hughes GRV. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. BMJ 1983; 287: 1088-9.
2. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
3. Levine SR, Crofts JW, Lesser GR, Floberg J, Welch KM. Visual symptoms associated with the presence of a lupus anticoagulant. Ophthalmology 1988; 95: 686-92.
4. Hartnett ME, Pruett RE, DaSilva KC, Burkart PT. Antiphospholipid antibody syndrome associated with microscotomata. Am J Ophthalmol 1994; 118: 397-8.
5. Wiechens B, Schroder JO, Potzsch B, Rochels R. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. Am J Ophthalmol 1997; 123: 848-50.
6. Castanon C, Amigo ME, Banales JL, Nava A, Reyes PA. Ocular vaso-occlusive disease in primary antiphospholipid syndrome. Ophthalmology 1995; 102: 256-62.
7. McKibbin M, Parulekar M, Innes JR. Recurrent retinal artery occlusion after the disappearance of lupus anticoagulant. Eye 1998; 12: 893-4.
8. Palimar P, Cota N. Asymptomatic vaso-occlusive retinopathy in Hughes' syndrome. Eye 1998; 12: 320-1.
9. Acheson JF, Gregson RM, Merry P, Schulenburg WE. Vasoocclusive retinopathy in the primary anti-phospholipid antibody syndrome. Eye 1991; 5: 48-55.
10. Digre KB, Durcan FJ, Branch DW, Jacobson DM, Varner MW, Baringer JR. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol 1989; 25: 228-32.
11. Reino S, Munoz-Rodriguez FI, Cervera R, Espinosa G, Font J, lngelmo M. Optic neuropathy in the 'primary' antiphospholipid syndrome: report of a case and review of the literature. Clin Rheumatol 1997; 16: 629-31.
12. Dori D, Gelfand VA, Brenner B, Miller B. Cilioretinal artery occlusion: an ocular complication of primary antiphospholipid syndrome. Retina 1997; 17: 555-7.
13. Giordano N, Senesi M, Battisti E, Antiphospholipid antibodies in patients with retinal vascular occlusions. Acta Ophthalmol Scand 1998; 76: 128-9.
14. Booth CD. A drug interaction between danazol and warfarin. Pharm J 1993; 242: 439-40.
15. Galli M, Comfurius P, Maassen C, Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-7.
16. Roubey RA. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other 'antiphospholipid' autoantibodies. Blood 1994; 84: 2854-67.
17. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
18. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; II: 1211-4.
19. Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust NZ J Med 1990; 20: 231-6.
20. Levine SR, Welch KM. The spectrum of neurologic disease associated with antiphospholipid antibodies: lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 1987; 44: 876-83.
21. Coull BM, Goodnight SH. Antiphospholipid antibodies, prethrombotic states, and stroke. Stroke 1990; 21: 1370-4.
22. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet GynecoI1992; 80: 614-20.
23. Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GR. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 568-7l.
24. Levine SR, Welch KMA. Cerebrovascular ischaemia associated with lupus anticoagulant. Stroke 1987; 18: 257-63.
25. Liou HH, Wang CR, Chen Q, Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus 1996; 5: 307-12.
26. Harris EN, Gharavi AE, Hughes GR. Anti-phospholipid antibodies. Clin Rheum Dis 1985; 11: 591-609.
27. Graham EM, Spalton DJ, Barnard RO, Garner A, Russell RW. Cerebral and retinal vascular changes in systemic lupus erythematosus. Ophthalmology 1985; 92: 444-8.
28. Lie JT. Vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis, or both? J Rheumatol 1989; 16: 713-5.
29. Hughes GRV, Asherson RA, Khamashta MA. Antiphospholipid antibodies: their clinical significance. Topical Reviews (Arthritis and Rheumatism Council) 1990; 16: 1-4.
30. Asherson RA, Merry P, Acheson JF, Harris EN, Hughes GR. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis 1989; 48: 358-6l.
31. Rosove MH, Brewer PM. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303-8.
32. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993-7.
33. Derksen RHWM, de Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulation treatment. Ann Rheum Dis 1993; 52: 689-92.
34. Derksen RH, Hasselaar P, Blokzijl L, Gmelig Meyling FH, De Groot PG. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. Ann Rheum Dis 1988; 47: 364-71.
35. Kavanagh A. Danazol therapy in thrombocytopenia associated with the antiphospholipid antibody syndrome. Ann Intern Med 1994; 121: 767-8.